Cystatin C as a biomarker of chronic kidney disease: latest developments
Introduction Chronic kidney disease (CKD) is common, occurring in over 10% of individuals globally, and is increasing in prevalence. The limitations of traditional biomarkers of renal dysfunction, such as serum creatinine, have been well demonstrated in the literature. Therefore, augmenting clinical...
Zapisane w:
| Główni autorzy: | , , |
|---|---|
| Format: | Revisão |
| Język: | angielski |
| Wydane: |
2020
|
| Dostęp online: | https://doi.org/10.1080/14737159.2020.1768849 |
| Etykiety: |
Dodaj etykietę
Nie ma etykietki, Dołącz pierwszą etykiete!
|